11/14/2024
6:15 PM | ASLAN Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G | |
09/06/2024
6:41 AM | ASLAN Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
08/08/2024
10:36 AM | ASLAN Pharmaceuticals (Subject)
UBS Group AG (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2024
6:29 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
6:29 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2024
11:15 PM | ASLAN Pharmaceuticals (Filer)
| Form EFFECT | |
06/14/2024
3:46 PM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2024
3:30 PM | ASLAN Pharmaceuticals (Subject)
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
| Form F-6 POS | |
06/12/2024
3:32 PM | ASLAN Pharmaceuticals (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
05/09/2024
6:10 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
6:41 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for ASLN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/22/2024
7:29 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024
7:15 AM | ASLAN Pharmaceuticals (Filer)
| Form 424B5 | |
04/12/2024
7:10 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024
5:37 AM | ASLAN Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/12/2024
5:27 AM | ASLAN Pharmaceuticals (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/12/2024
5:05 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2024
11:15 PM | ASLAN Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024
1:11 PM | ASLAN Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/21/2024
3:42 PM | ASLAN Pharmaceuticals (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G | |
03/14/2024
5:24 AM | ASLAN Pharmaceuticals (Filer)
| Form 424B5 | |
03/13/2024
6:27 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
7:03 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
3:45 PM | ASLAN Pharmaceuticals (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
9:22 AM | ASLAN Pharmaceuticals (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/06/2024
9:38 AM | ASLAN Pharmaceuticals (Subject)
UBS Group AG (Filed by)
| Form SC 13G | |
